Amy Tiersten

Trials

Studies that name Amy Tiersten as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 17:34 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT06040970 · Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

  Icahn School of Medicine at Mount Sinai · recruiting · Ovarian Cancer, Malignant Neoplasm of Uterus · principal investigator
• Ph1/Ph2
  NCT05095207 · Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer

  Icahn School of Medicine at Mount Sinai · recruiting · Breast Cancer, Metastasis · principal investigator
• Ph2
  NCT04561817 · To Evaluate the Safety and Efficacy of Ipatasertib (GDC-0068) in Combination With Paclitaxel in Platinum-resistant Recurrent Epithelial Ovarian Cancer

  Icahn School of Medicine at Mount Sinai · withdrawn · Ovarian Neoplasms · principal investigator
• Ph1
  NCT03430518 · Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer

  Amy Tiersten · completed · HER2-Negative Metastatic Breast Cancer, Recurrent Ovarian Cancer · principal investigator
• Ph1/Ph2
  NCT03304080 · Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast

  Icahn School of Medicine at Mount Sinai · active not recruiting · Breast Neoplasms, Breast Diseases · principal investigator
• Ph1
  NCT02936206 · Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.

  Icahn School of Medicine at Mount Sinai · terminated · Breast Cancer · principal investigator
• Ph2
  NCT02531932 · Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer

  Amy Tiersten · completed · Breast Cancer · principal investigator
• N/A
  NCT02081612 · Comparison of Nutrition Education Alone or With Acupuncture for Weight Loss in Breast Cancer Patients Post-Chemotherapy

  Icahn School of Medicine at Mount Sinai · completed · Breast Cancer · study director
• Ph2
  NCT01127763 · RAD001 Plus Carboplatin in Breast Cancer Patients

  NYU Langone Health · completed · Breast Cancer · principal investigator
• Ph1
  NCT00352300 · Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer

  Gynecologic Oncology Group · completed · Fallopian Tube Carcinoma, Infectious Disorder, Neutropenia · principal investigator
• Ph2
  NCT00313612 · Oxaliplatin and Topotecan in Advance Ovarian Cancer

  National Cancer Institute (NCI) · terminated · Recurrent Ovarian Epithelial Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 17:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Gynecologic Oncology Group
  U10CA027469 · NCI · GYNECOLOGIC ONCOLOGY GROUP · PI Philip J. DiSaia · fiscal years 1985 to 2013
  Named on NCT00352300